Anebulo Pharmaceuticals Competitors and Similar CompaniesClear all

InDevR's competitors and similar companies include Jubilant Pharma, Nextbiotics and PathoVax.
InDevR
InDevR
InDevR provides new analytical technologies that enable accelerated development and manufacturing of vaccines and other biotherapeutics.
Jubilant Pharma
Jubilant Pharma
Jubilant Pharma is a pharmaceutical company that specializes in the research, development, and manufacturing of radiopharma and allergy therapy products.
Nextbiotics
Nextbiotics
Nextbiotics is a company developing antibiotic alternatives for antibiotic-resistant infections.
PathoVax
PathoVax
PathoVax is a biotechnology company focused on the development of a universal human papillomavirus (HPV) vaccine to provide prophylaxis against HPV-related cancers and diseases.
Founding Date
Founding Date
2003
Founding Date
2005
Founding Date
2017
Founding Date
2014
Type
Type
Private
Type
Subsidiary
Type
Private
Type
Private
Tags
Locations
Locations
Boulder, US HQ
Locations
Yardley, US HQ
Melbourne, AU
Merelbeke, BE
Montreal, CA
Shanghai, CN
Shanghai, CN
Greater Noida, IN
see more
Locations
Oakland, US HQ
Locations
Baltimore, US HQ
Employees
Employees
274% increase
Employees
1682% increase
Employees
3
Employees
3

Funding

Latest funding round
Latest funding round
$ 7m (almost 7 years ago)
Latest funding round
N/A
Latest funding round
$ 750k (over 8 years ago)
Latest funding round
N/A
Total funding raised
Total funding raised
$ 7m
Total funding raised
N/A
Total funding raised
$ 750k
Total funding raised
N/A
For sources of this data, please see the company profile

View Company Profiles

Jubilant Pharma
HQ
Yardley, US

Jubilant Pharma is a pharmaceutical company that specializes in the research, development, and manufacturing of radiopharma and allergy therapy products.

View company
Nextbiotics
HQ
Oakland, US
Employees
3

Nextbiotics is a company developing antibiotic alternatives for antibiotic-resistant infections.

View company
PathoVax
HQ
Baltimore, US
Employees
3

PathoVax is a biotechnology company focused on the development of a universal human papillomavirus (HPV) vaccine to provide prophylaxis against HPV-related cancers and diseases.

View company